In the last trading session, 6.9 million shares of the Conduit Pharmaceuticals Inc (NASDAQ:CDT) were traded, and its beta was 2.23. Most recently the company’s share price was $1.12, and it changed around -$0.04 or -3.38% from the last close, which brings the market valuation of the company to $5.28M. CDT currently trades at a discount to its 52-week high of $392.00, offering almost -34900.0% off that amount. The share price’s 52-week low was $1.09, which indicates that the current value has risen by an impressive 2.68% since then.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Instantly CDT has showed a red trend with a performance of -3.38% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.2565 on recent trading dayincreased the stock’s daily price by 10.86%. The company’s shares are currently down -83.66% year-to-date, but still down -8.13% over the last five days. On the other hand, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -54.81% down in the 30-day period.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Oct 31, 2024. The former held 2.33 shares worth $2637.0, making up 0.06% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 2.03 shares worth around $2292.0, which represents about 0.06% of the total shares outstanding.